Log in
Enquire now
‌

US Patent 12121610 Compositions and methods for targeted delivery to cells

Patent 12121610 was granted and assigned to RECODE THERAPEUTICS, INC. on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
RECODE THERAPEUTICS
RECODE THERAPEUTICS
0
Current Assignee
RECODE THERAPEUTICS
RECODE THERAPEUTICS
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
121216100
Patent Inventor Names
Brandon A. Wustman0
Mirko Hennig0
Vladimir Kharitonov0
Rumpa Bhattacharjee0
Jackson Eby0
Date of Patent
October 22, 2024
0
Patent Application Number
183116160
Date Filed
May 3, 2023
0
Patent Citations
‌
US Patent 10137086 Lipid-derived neutral nanoparticles
0
‌
US Patent 10232055 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 10717982 Stabilization of poly(A) sequence encoding DNA sequences
0
‌
US Patent 10898574 Delivery and formulation of engineered nucleic acids
0
‌
US Patent 11135312 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
0
‌
US Patent 11173190 Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
0
‌
US Patent 11247968 Lipocationic dendrimers and uses thereof
0
‌
US Patent 11253605 Codon-optimized CFTR MRNA
0
...
Patent Primary Examiner
‌
Celeste A Roney
0
Patent abstract

Described herein are compositions, kits, and methods for potent delivery to a cell of a subject. The cell can be of a particular cell type, such as a basal cell, a ciliated cell, or a secretory cell. In some cases, the cell can be a lung cell of a particular cell type. Also described herein are pharmaceutical compositions comprising a therapeutic or prophylactic agent assembled to a lipid composition. The lipid composition can comprise an ionizable cationic lipid, a phospholipid, and a selective organ targeting lipid. Further described herein are high-potency dosage forms of a therapeutic or prophylactic agent formulated with a lipid composition.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12121610 Compositions and methods for targeted delivery to cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.